Education
About Us
Working with TipRanks
Follow Us
Q-linea AB (SE:QLINEA)
:QLINEA
QLINEA Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.03 - kr0.99
Previous CloseN/A
Volume6.05M
Average Volume (3M)22.77M
Market Cap
kr300.27M
Enterprise ValueN/A
Total Cash (Recent Filing)kr68.03M
Total Debt (Recent Filing)kr51.09M
Price to Earnings (P/E)―
Beta3.67
Next Earnings
Jul 10, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding6,430,039,600
10 Day Avg. Volume20,431,349
30 Day Avg. Volume22,772,697
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.71
Price to Sales (P/S)0.00
P/FCF Ratio-1.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Q-linea AB News
PremiumCompany Announcements
Q-linea AB Expands Share Capital with New Issuance
PremiumCompany Announcements
Q-linea AB Proposes Reverse Share Split and Capital Reduction
PremiumCompany Announcements
Q-linea AB Announces 2025 Annual General Meeting and Key Resolutions
PremiumCompany Announcements
Q-linea AB Successfully Exercises Series TO1 Warrants
PremiumCompany Announcements
Q-linea AB Concludes Trading in Warrants Series TO 1
PremiumCompany Announcements
Q-linea AB Announces Board Member Nominations for 2025
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
QLINEA FAQ
What was Q-linea AB’s price range in the past 12 months?
Q-linea AB lowest stock price was kr0.03 and its highest was kr0.98 in the past 12 months.
What is Q-linea AB’s market cap?
Q-linea AB’s market cap is kr300.27M.
When is Q-linea AB’s upcoming earnings report date?
Q-linea AB’s upcoming earnings report date is Jul 10, 2025 which is in 25 days.
How were Q-linea AB’s earnings last quarter?
Q-linea AB released its earnings results on Apr 14, 2025. The company reported -kr0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.02.
Is Q-linea AB overvalued?
According to Wall Street analysts Q-linea AB’s price is currently Overvalued.
Does Q-linea AB pay dividends?
Q-linea AB does not currently pay dividends.
What is Q-linea AB’s EPS estimate?
Q-linea AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Q-linea AB have?
Q-linea AB has 6,430,039,600 shares outstanding.
What happened to Q-linea AB’s price movement after its last earnings report?
Q-linea AB reported an EPS of -kr0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -8.511%.
Which hedge fund is a major shareholder of Q-linea AB?
Currently, no hedge funds are holding shares in SE:QLINEA
Company Description
Q-linea AB
Q-linea AB (QLINEA) is a Swedish biotechnology company specializing in the development of advanced diagnostic systems for healthcare providers. The company focuses primarily on creating innovative solutions for the rapid diagnosis of infectious diseases. Q-linea's core product, the ASTar system, is designed to offer fast and precise antimicrobial susceptibility testing, helping medical professionals make informed treatment decisions more efficiently.
Technical Analysis
Acarix AB
―
Clinical Laserthermia Systems AB Class B
―
Luxbright AB
―
SciBase Holding AB
―
SpectraCure AB
―